Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12


Isolation and Characterization of a Novel Gammaherpesvirus from a Microbat Cell Line.

Shabman RS, Shrivastava S, Tsibane T, Attie O, Jayaprakash A, Mire CE, Dilley KE, Puri V, Stockwell TB, Geisbert TW, Sachidanandam R, Basler CF.

mSphere. 2016 Feb 17;1(1). pii: e00070-15. doi: 10.1128/mSphere.00070-15. eCollection 2016 Jan-Feb.


A high throughput Cre-lox activated viral membrane fusion assay identifies pharmacological inhibitors of HIV entry.

Esposito AM, Cheung P, Swartz TH, Li H, Tsibane T, Durham ND, Basler CF, Felsenfeld DP, Chen BK.

Virology. 2016 Mar;490:6-16. doi: 10.1016/j.virol.2015.10.013. Epub 2016 Jan 21.


Influenza human monoclonal antibody 1F1 interacts with three major antigenic sites and residues mediating human receptor specificity in H1N1 viruses.

Tsibane T, Ekiert DC, Krause JC, Martinez O, Crowe JE Jr, Wilson IA, Basler CF.

PLoS Pathog. 2012;8(12):e1003067. doi: 10.1371/journal.ppat.1003067. Epub 2012 Dec 6.


Seroprevalence of pandemic influenza viruses, New York, New York, USA, 2004.

Weisfuse IB, Tsibane T, Konty KJ, Egger JR, Waddell EN, Rahmat S, Harris E, Olson DR, Basler CF.

Emerg Infect Dis. 2012 Nov;18(11):1905-7. doi: 10.3201/eid1811.120156. No abstract available.


1976 and 2009 H1N1 influenza virus vaccines boost anti-hemagglutinin stalk antibodies in humans.

Miller MS, Tsibane T, Krammer F, Hai R, Rahmat S, Basler CF, Palese P.

J Infect Dis. 2013 Jan 1;207(1):98-105. doi: 10.1093/infdis/jis652. Epub 2012 Oct 18.


Human monoclonal antibodies to pandemic 1957 H2N2 and pandemic 1968 H3N2 influenza viruses.

Krause JC, Tsibane T, Tumpey TM, Huffman CJ, Albrecht R, Blum DL, Ramos I, Fernandez-Sesma A, Edwards KM, García-Sastre A, Basler CF, Crowe JE Jr.

J Virol. 2012 Jun;86(11):6334-40. doi: 10.1128/JVI.07158-11. Epub 2012 Mar 28.


Epitope-specific human influenza antibody repertoires diversify by B cell intraclonal sequence divergence and interclonal convergence.

Krause JC, Tsibane T, Tumpey TM, Huffman CJ, Briney BS, Smith SA, Basler CF, Crowe JE Jr.

J Immunol. 2011 Oct 1;187(7):3704-11. doi: 10.4049/jimmunol.1101823. Epub 2011 Aug 31.


A broadly neutralizing human monoclonal antibody that recognizes a conserved, novel epitope on the globular head of the influenza H1N1 virus hemagglutinin.

Krause JC, Tsibane T, Tumpey TM, Huffman CJ, Basler CF, Crowe JE Jr.

J Virol. 2011 Oct;85(20):10905-8. doi: 10.1128/JVI.00700-11. Epub 2011 Aug 17.


Protection of mice against lethal challenge with 2009 H1N1 influenza A virus by 1918-like and classical swine H1N1 based vaccines.

Manicassamy B, Medina RA, Hai R, Tsibane T, Stertz S, Nistal-Villán E, Palese P, Basler CF, García-Sastre A.

PLoS Pathog. 2010 Jan 29;6(1):e1000745. doi: 10.1371/journal.ppat.1000745.


Naturally occurring human monoclonal antibodies neutralize both 1918 and 2009 pandemic influenza A (H1N1) viruses.

Krause JC, Tumpey TM, Huffman CJ, McGraw PA, Pearce MB, Tsibane T, Hai R, Basler CF, Crowe JE Jr.

J Virol. 2010 Mar;84(6):3127-30. doi: 10.1128/JVI.02184-09. Epub 2009 Dec 30.


Neutralizing anti-influenza virus monoclonal antibodies: therapeutics and tools for discovery.

Martinez O, Tsibane T, Basler CF.

Int Rev Immunol. 2009;28(1):69-92. doi: 10.1080/08830180802593540. Review.


Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors.

Yu X, Tsibane T, McGraw PA, House FS, Keefer CJ, Hicar MD, Tumpey TM, Pappas C, Perrone LA, Martinez O, Stevens J, Wilson IA, Aguilar PV, Altschuler EL, Basler CF, Crowe JE Jr.

Nature. 2008 Sep 25;455(7212):532-6. doi: 10.1038/nature07231. Epub 2008 Aug 17. Erratum in: Nature. 2012 Oct 25;490(7421):570.

Supplemental Content

Loading ...
Support Center